2Sanin LH, Gonzalez-Cossio T, Romieu I, et al. Accumulation of lead in bone and its effects on health[J]. Salud Publica Mex, 1998, 40(4):359- 368.
3Gulson BL, Mizon K J, Palmer JM, et al. Contribution of lead from calcium supplements to blood lead[J]. Environ Health Perspect, 2001,109(3):283 - 288.
4Mahaffey KR. Nutrition and lead: strategies for public health[J]. Environ Health perspect, 1995,103(Suppl 6):191 - 196.
5Dowd TL, Rosen JF, Mints L, et al. The effect of Pb(2+) on the structure and hydroxyapatite binding properties of osteocalcin[J]. Biochim Biophys Acta, 2001,1535(2):153-163.
6Kristal- Boneh E, Froom P, Yerushalmi N, et al. Calcitropic hormones and occupational lead exposure[J]. Am J Epidemiol, 1998,147(5):458- 463.
7Barger-Lux MJ, Heaney RP, Hayes J, etal. Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density[J]. Calcif Tissue Int, 1995,57(2):161- 162.
8Schwartz BS, Lee BK, Lee GS, et al. Associations of blood lead, dimercaptosuccinic acid - chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta] aminolevulinic acid dehydratase genes[J]. Environ Health Perspect, 2000, 108 (10): 949- 954.
9Schwartz BS, Stewart WF, Kelsey KT, et al. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers[J]. Environ Health Perspect, 2000,108(3): 199- 203.
10Vandevyver C, Wylin T, Cassiman JJ, et al. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women[J]. J Bone Miner Res, 1997, 12(2):241 - 247.